TMEM237 and hepatocellular carcinoma: Furthermore, TMEM237 overexpression, frequently observed in HCC, has been shown to enhance HCC cell multiplication, movement, invasion, and epithelial-mesenchymal transition (EMT), correlating with poor clinical outcomes.